日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

B cell and aquaporin-4 antibody relationships with neuromyelitis optica spectrum disorder activity

B细胞和水通道蛋白4抗体与视神经脊髓炎谱系疾病活动的关系

期刊:Annals of Clinical and Translational Neurology
影响因子:3.9
doi:10.1002/acn3.52171
Bennett, Jeffrey L; Pittock, Sean J; Paul, Friedemann; Kim, Ho Jin; Irani, Sarosh R; O'Connor, Kevin C; Patterson, Kristina R; Smith, Michael A; Gunsior, Michele; Mittereder, Nanette; Rees, William A; Cimbora, Daniel; Cree, Bruce A C
B细胞
细胞生物学
神经科学
免疫/内分泌
发表日期：2024
文献求助 收藏

Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder

发作时血清神经丝轻链水平可预测发作后残疾恶化，且可被伊奈利珠单抗减轻：视神经脊髓炎谱系障碍四种潜在生物标志物的分析

期刊:Journal of Neurology Neurosurgery and Psychiatry
影响因子:7.5
doi:10.1136/jnnp-2022-330412
Aktas, Orhan; Hartung, Hans-Peter; Smith, Michael A; Rees, William A; Fujihara, Kazuo; Paul, Friedemann; Marignier, Romain; Bennett, Jeffrey L; Kim, Ho Jin; Weinshenker, Brian G; Pittock, Sean J; Wingerchuk, Dean M; Cutter, Gary; She, Dewei; Gunsior, Michele; Cimbora, Daniel; Katz, Eliezer; Cree, Bruce A
神经科学
发表日期：2023
文献求助 收藏

Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum

视神经脊髓炎谱系障碍发作判定：磁共振成像和生物标志物在N-MOmentum中的应用证实标准

期刊:Multiple Sclerosis Journal
影响因子:5
doi:10.1177/13524585231172145
Weinshenker, Brian G; Wingerchuk, Dean M; Green, Ari J; Bennett, Jeffrey L; Kim, Ho Jin; Pittock, Sean J; Fujihara, Kazuo; Paul, Friedemann; Cutter, Gary; Marignier, Romain; Aktas, Orhan; Hartung, Hans-Peter; She, Dewei; Smith, Michael; Rees, William; Patterson, Kristina; Cimbora, Daniel; Katz, Eliezer; Cree, Bruce Ac
神经科学
发表日期：2023
文献求助 收藏

Inebilizumab reduces neuromyelitis optica spectrum disorder risk independent of FCGR3A polymorphism

Inebilizumab 可降低视神经脊髓炎谱系障碍的风险，且与 FCGR3A 多态性无关

期刊:Annals of Clinical and Translational Neurology
影响因子:3.9
doi:10.1002/acn3.51911
Kim, Ho Jin; Aktas, Orhan; Patterson, Kristina R; Korff, Schaun; Kunchok, Amy; Bennett, Jeffrey L; Weinshenker, Brian G; Paul, Friedemann; Hartung, Hans-Peter; Cimbora, Daniel; Smith, Michael A; Mittereder, Nanette; Rees, William A; She, Dewei; Cree, Bruce A C
FCGR3A
神经科学
发表日期：2023
文献求助 收藏

Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial

Inebilizumab治疗IgG4相关疾病的疗效和安全性：一项随机对照试验方案

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-023-00593-7
Perugino, Cory; Culver, Emma L; Khosroshahi, Arezou; Zhang, Wen; Della-Torre, Emanuel; Okazaki, Kazuichi; Tanaka, Yoshiya; Löhr, Matthias; Schleinitz, Nicolas; Falloon, Judith; She, Dewei; Cimbora, Daniel; Stone, John H
IgG
发表日期：2023
文献求助 收藏

Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo-controlled, multicentre phase 2/3 trial

B细胞耗竭与视神经脊髓炎谱系障碍发作风险之间的关联：一项来自N-MOmentum研究的探索性分析，该研究是一项双盲、随机、安慰剂对照、多中心2/3期试验。

期刊:EBioMedicine
影响因子:10.8
doi:10.1016/j.ebiom.2022.104321
Bennett, Jeffrey L; Aktas, Orhan; Rees, William A; Smith, Michael A; Gunsior, Michele; Yan, Li; She, Dewei; Cimbora, Daniel; Pittock, Sean J; Weinshenker, Brian G; Paul, Friedemann; Marignier, Romain; Wingerchuk, Dean; Cutter, Gary; Green, Ari; Hartung, Hans-Peter; Kim, Ho Jin; Fujihara, Kazuo; Levy, Michael; Katz, Eliezer; Cree, Bruce A C
B细胞
细胞生物学
神经科学
免疫/内分泌
发表日期：2022
文献求助 收藏

Long-term efficacy and safety of inebilizumab in neuromyelitis optica spectrum disorder: Analysis of aquaporin-4-immunoglobulin G-seropositive participants taking inebilizumab for ⩾4 years in the N-MOmentum trial

伊奈比珠单抗治疗视神经脊髓炎谱系障碍的长期疗效和安全性：N-MOmentum试验中接受伊奈比珠单抗治疗≥4年的AQP4-IgG血清阳性患者的分析

期刊:Multiple Sclerosis Journal
影响因子:5
doi:10.1177/13524585211047223
Rensel, Mary; Zabeti, Aram; Mealy, Maureen A; Cimbora, Daniel; She, Dewei; Drappa, Jorn; Katz, Eliezer
IgG
AQP4
神经科学
发表日期：2022
文献求助 收藏

Population Pharmacokinetic Modeling of Inebilizumab in Subjects with Neuromyelitis Optica Spectrum Disorders, Systemic Sclerosis, or Relapsing Multiple Sclerosis

伊奈比珠单抗在视神经脊髓炎谱系疾病、系统性硬化症或复发型多发性硬化症患者中的群体药代动力学模型

期刊:Clinical Pharmacokinetics
影响因子:4
doi:10.1007/s40262-021-01071-5
Yan, Li; Kimko, Holly; Wang, Bing; Cimbora, Daniel; Katz, Eliezer; Rees, William A
神经科学
系统性硬化症
多发性硬化症
免疫/内分泌
发表日期：2022
文献求助 收藏

Pharmacodynamic modelling and exposure-response assessment of inebilizumab in subjects with neuromyelitis optica spectrum disorders

伊奈利珠单抗在视神经脊髓炎谱系障碍患者中的药效学建模和暴露-反应评估

期刊:British Journal of Clinical Pharmacology
影响因子:3
doi:10.1111/bcp.15332
Yan, Li; Wang, Bing; She, Dewei; Mitchell, Ben; Criste, Ryan; Cimbora, Daniel; Katz, Eliezer; Rees, William A
神经科学
发表日期：2022
文献求助 收藏

Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum Disorder

视神经脊髓炎谱系障碍患者接受伊尼利珠单抗治疗的N-MOmentum试验中的残疾结局

期刊:Neurology-Neuroimmunology & Neuroinflammation
影响因子:7.5
doi:10.1212/NXI.0000000000000978
Marignier, Romain; Bennett, Jeffrey L; Kim, Ho Jin; Weinshenker, Brian G; Pittock, Sean J; Wingerchuk, Dean; Fujihara, Kazuko; Paul, Friedemann; Cutter, Gary R; Green, Ari J; Aktas, Orhan; Hartung, Hans-Peter; Lublin, Fred D; Williams, Ian M; Drappa, Jorn; She, Dewei; Cimbora, Daniel; Rees, William; Smith, Michael; Ratchford, John N; Katz, Eliezer; Cree, Bruce A C
神经科学
发表日期：2021
文献求助 收藏